Section Arrow
PLRZ.NASDAQ
- Polyrizon Ltd.
Quotes are at least 15-min delayed:2026/04/07 10:32 EDT
Regular Hours
Last
 11.22
-1.08 (-8.78%)
Day High 
11.97 
Prev. Close
12.3 
1-M High
15.5 
Volume 
11.83K 
Bid
10.5
Ask
11.22
Day Low
11 
Open
11.41 
1-M Low
10.6695 
Market Cap 
12.81M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.84 
20-SMA 13.31 
50-SMA 13.52 
52-W High 2,235 
52-W Low 2.88 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.90/--
Enterprise Value
12.81M
Balance Sheet
Book Value Per Share
12.94
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LNAILunai Bioworks Inc.0.3851+0.1031+36.56%-- 
SILOSilo Pharma0.4837+0.1279+35.95%-- 
TERNTerns Pharmaceuticals52.61-0.17-0.32%-- 
CUECue Biopharma0.1804+0.0034+1.92%-- 
QNCXQuince Therapeutics0.0963+0.0088+10.06%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.